These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33393765)

  • 1. Quantitative Structure-Activity Relationship (QSAR) Model for the Severity Prediction of Drug-Induced Rhabdomyolysis by Using Random Forest.
    Zhou Y; Li S; Zhao Y; Guo M; Liu Y; Li M; Wen Z
    Chem Res Toxicol; 2021 Feb; 34(2):514-521. PubMed ID: 33393765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management.
    Wen Z; Liang Y; Hao Y; Delavan B; Huang R; Mikailov M; Tong W; Li M; Liu Z
    Drug Discov Today; 2019 Jan; 24(1):9-15. PubMed ID: 29902520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico prediction of drug-induced rhabdomyolysis with machine-learning models and structural alerts.
    Cui X; Liu J; Zhang J; Wu Q; Li X
    J Appl Toxicol; 2019 Aug; 39(8):1224-1232. PubMed ID: 31006880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Activity Relationship (SAR) Model for Predicting Teratogenic Risk of Antiseizure Medications in Pregnancy by Using Support Vector Machine.
    Kang L; Duan Y; Chen C; Li S; Li M; Chen L; Wen Z
    Front Pharmacol; 2022; 13():747935. PubMed ID: 35281912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quantitative structure-activity relationship model for prediction of cardiotoxicity of chemical components in traditional Chinese medicines].
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 49(3):551-556. PubMed ID: 28628163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADMET Evaluation in Drug Discovery. 18. Reliable Prediction of Chemical-Induced Urinary Tract Toxicity by Boosting Machine Learning Approaches.
    Lei T; Sun H; Kang Y; Zhu F; Liu H; Zhou W; Wang Z; Li D; Li Y; Hou T
    Mol Pharm; 2017 Nov; 14(11):3935-3953. PubMed ID: 29037046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancing Adverse Drug Reaction Prediction with Deep Chemical Language Model for Drug Safety Evaluation.
    Lin J; He Y; Ru C; Long W; Li M; Wen Z
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of QSAR Equations for Virtual Screening.
    Spiegel J; Senderowitz H
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAR and QSAR models of cyclooxygenase-1 (COX-1) inhibitors.
    Xi Y; Qin Z; Yan A
    SAR QSAR Environ Res; 2018 Oct; 29(10):755-784. PubMed ID: 30274533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSAR Modeling and Prediction of Drug-Drug Interactions.
    Zakharov AV; Varlamova EV; Lagunin AA; Dmitriev AV; Muratov EN; Fourches D; Kuz'min VE; Poroikov VV; Tropsha A; Nicklaus MC
    Mol Pharm; 2016 Feb; 13(2):545-56. PubMed ID: 26669717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
    Chang JT; Staffa JA; Parks M; Green L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SAR and QSAR study on the bioactivities of human epidermal growth factor receptor-2 (HER2) inhibitors.
    Qu D; Yan A; Zhang JS
    SAR QSAR Environ Res; 2017 Feb; 28(2):111-132. PubMed ID: 28235391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for rhabdomyolysis with HMG-CoA reductase inhibitors identified using a postmarketing surveillance database in Japan
.
    Hashiguchi M; Hakamata J; Shimizu M; Maruyama J; Shiga T; Mochizuki M
    Int J Clin Pharmacol Ther; 2018 Jul; 56(7):310-320. PubMed ID: 29701171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative structure-activity relationship models for predicting drug-induced liver injury based on FDA-approved drug labeling annotation and using a large collection of drugs.
    Chen M; Hong H; Fang H; Kelly R; Zhou G; Borlak J; Tong W
    Toxicol Sci; 2013 Nov; 136(1):242-9. PubMed ID: 23997115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification and QSAR models of leukotriene A4 hydrolase (LTA4H) inhibitors by machine learning methods.
    Qin R; Wang H; Yan A
    SAR QSAR Environ Res; 2021 May; 32(5):411-431. PubMed ID: 33896285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapacuronium bromide: a review of its use in anaesthetic practice.
    Onrust SV; Foster RH
    Drugs; 1999 Nov; 58(5):887-918. PubMed ID: 10595867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADMET Evaluation in Drug Discovery. Part 17: Development of Quantitative and Qualitative Prediction Models for Chemical-Induced Respiratory Toxicity.
    Lei T; Chen F; Liu H; Sun H; Kang Y; Li D; Li Y; Hou T
    Mol Pharm; 2017 Jul; 14(7):2407-2421. PubMed ID: 28595388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cheminformatics-aided pharmacovigilance: application to Stevens-Johnson Syndrome.
    Low YS; Caster O; Bergvall T; Fourches D; Zang X; Norén GN; Rusyn I; Edwards R; Tropsha A
    J Am Med Inform Assoc; 2016 Sep; 23(5):968-78. PubMed ID: 26499102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Silico Prediction of Drug-Induced Liver Injury Based on Adverse Drug Reaction Reports.
    Zhu XW; Li SJ
    Toxicol Sci; 2017 Aug; 158(2):391-400. PubMed ID: 28521054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal Piecewise Linear Regression Algorithm for QSAR Modelling.
    Cardoso-Silva J; Papadatos G; Papageorgiou LG; Tsoka S
    Mol Inform; 2019 Mar; 38(3):e1800028. PubMed ID: 30251339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.